Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MAP2K1 P124S
i
Other names:
MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5604
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MAP2K1 P124S
Melanoma
MAP2K1 P124S
Melanoma
trametinib
Sensitive: C3 – Early Trials
trametinib
Sensitive
:
C3
trametinib
Sensitive: C3 – Early Trials
trametinib
Sensitive
:
C3
MAP2K1 P124S
Melanoma
MAP2K1 P124S
Melanoma
dabrafenib
Resistant: C3 – Early Trials
dabrafenib
Resistant
:
C3
dabrafenib
Resistant: C3 – Early Trials
dabrafenib
Resistant
:
C3
MAP2K1 P124S
Melanoma
MAP2K1 P124S
Melanoma
vemurafenib
Resistant: C3 – Early Trials
vemurafenib
Resistant
:
C3
vemurafenib
Resistant: C3 – Early Trials
vemurafenib
Resistant
:
C3
MAP2K1 P124S
Melanoma
MAP2K1 P124S
Melanoma
selumetinib
Sensitive: C4 – Case Studies
selumetinib
Sensitive
:
C4
selumetinib
Sensitive: C4 – Case Studies
selumetinib
Sensitive
:
C4
MAP2K1 P124S
Melanoma
MAP2K1 P124S
Melanoma
PLX4720
Resistant: D – Preclinical
PLX4720
Resistant
:
D
PLX4720
Resistant: D – Preclinical
PLX4720
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login